For the past few years, the United States has been engaged in a public policy debate about how to reform the healthcare system to assure access to care while cost containment. Underlying the deliberations is a concern that quality and cost containment are a trade off that is, that efforts to contain costs inevitably result in lower quality of care. This concern may explain, in part, why the effort to pass reform legislation two years ago was not successful.
Introduction
For the past few years, the United States has been engaged in a public policy debate about how to reform the healthcare system to assure access to care while cost containment. Underlying the deliberations is a concern that quality and cost containment are a trade off that is, that efforts to contain costs inevitably result in lower quality of care. This concern may explain, in part, why the effort to pass reform legislation two years ago was not successful.
However, quality health care was neither defined nor debated; the concepts and goals of cost containment were neither explored nor explained; and the relation between the two was never discussed. Therefore, the possibility that there is no direct relation or even an inverse relation between quality and cost containment was never raised. Without any public consensus about what is meant by either quality or cost containment, it is difficult to evaluate their relation to each other fairly.
The relation between cost containment and quality is an issue of universal interest. In this paper, we present the issue in the United States and discuss why the concepts of quality and cost containment may be poorly understood. We evaluate how the managed care phenomenon affects public perceptions of the relation between quality and cost containment. And we propose a framework for discussions on future reforms that are based on our understanding and definitions of quality, cost, and cost containment. We think a better framework for discussion is necessary to reach a national consensus on reform of health care.
Background
In the United States, healthcare expenditures are rising faster than the rest of the economy despite various efforts to contain them. ' Consequently, the share of gross national product (GNP) spent on health care is growing; the share in the United States is the highest in the world.2 Unlike many western nations, the United States has made fairly limited use of controls on system capacity or prices. The unique United States contribution to cost containment is its focus on control through financial incentives and the micromanagement of medical practice.3 The United
States recently ended a long and unsuccessful debate about healthcare reform. That debate was characterised by a lack of consensus on an appropriate strategy for cost containment.
Initially support for President Clinton's plan was high. 4 Most Americans favoured a plan that would assure universal access and contain costs. Quality of care was not part of the debate.5 However, public support eroded quickly, showing significant differences of opinion about the goals of reform and the means to achieve them. Being clear about what costs and expenditures mean affects any assessment of cost saving technology. Some technologies may reduce unit costs but not total expenditures. Take the example of laparoscopic cholecystectomy. This procedure is a less expensive alternative to traditional surgical removal of the gall bladder. However, researchers at United States Healthcare (a managed care company) recently documented that provider response to this new technology was to increase the number of cholecystectomies, so the lower unit cost was offset by higher volume. The cost saving technology ultimately increased total expenditures for treatment of gall bladder disease. ' However, the study did not include lost productivity in the analysis. That is another potentially relevant cost that might be considered when cost savings are evaluated. If patients who receive the laparoscopic procedure return to work sooner than those who receive the traditional surgical procedure, then the total cost of the episode might be considered lower. In this case, the new procedure may reduce the employer's expenditures for personnel but not for healthcare benefits. TIME FRAME
The time frame for talking about costs and expenditures is also unclear. United States businesses are often criticised for focusing on short term rather than long term gains. This seems to fit the American penchant for immediate forms of gratification. The same could be said of health policy in the United States.
Policy makers seem to be searching for the quick solution that will reduce expenditures in the short term rather than investing in services that might reduce expenditures in the long run.
The time frame is important because some strategies to contain expenditures may take time to pay off. Sometimes increasing use now can increase savings later. Preventive care is a good example. A substantial portion of the burden of illness is preventable. So investments in at least some preventive services should reduce aggregate health expenditures in the long term by reducing the need for medical care.1' However, some United States insurance companies have been reluctant to finance a broad range of preventive services. The savings may occur in the long term but subscribers do not have a long term commitment to remain enrolled with a particular plan. Thus, the savings may not accrue to the plan that made the investment, an interesting consequence of a multipayer system. Poor quality is expensive and improvements in quality can reduce costs.
In fact, the principles of total quality management and continuous quality improvement have been enthusiastically embraced by some segments of the healthcare industry, although the public may not be aware of it. Applications of total quality management and continuous quality improvement to health care also have produced encouraging results that show an inverse relation between quality and cost in some instances. It is not clear whether the healthcare industry as a whole or the general public would accept this alternative view of the relation between quality and cost.
RESEARCH ON OUTCOMES
Several clinicians in the United States have argued that a new paradigm is needed for clinical practice based on a better understanding of the relation between process and outcomes.2'-23 Wennberg2' has been one of the most ardent champions for better evidence of effective medical practices. His work has helped establish the legitimacy of research on outcomes which has also shown an inverse relation between quality and cost under some conditions. Fleming et a125 showed that watchful waiting, the low cost strategy for benign prostatic hypertrophy, often produced better results than more expensive, invasive alternatives. A study of Berwick29 has suggested several "worthy aims" for reform that could improve the quality of care and reduce costs and expenditures.
These include reducing inappropriate services, simplifying formularies, expanding the use of information technology, and eliminating underused inpatient services. Schoenbaum'has argued that trends are already emerging in the United States system that offer promise of better quality at a lower cost. These include the integration of systems of care, the development of research on outcomes and clinical guidelines, and the refinement of data on comparative performance.
MANAGED CARE EXPERIENCE
The managed care phenomenon in the United States health system has had a significant impact on the public's perception of the relation between quality and cost. The experience of the first prepaid group practices was that savings could be achieved without sacrificing quality. These organizations served as the prototypes for health maintenance organizations. An extensive body of research showed that per capita expenditures were 10% to 40% lower in the first health maintenance organizations than in fee for service practice, even when controlling for selection bias in choice of plans. 30 Comparisons between health maintenance organizations and fee for service plans in terms of quality often showed care to be better in health maintenance organisations, particularly in group or staff model plans.30
Initial savings in health maintenance organisations came from identifying and reducing the considerable slack in the American healthcare system, primarily through shifting care from inpatient to outpatient settings.30 However, there is no evidence that health maintenance organizations are better able to control expenditures in the long term than fee for service insurers. Expenditures of health maintenance organizations per capita are lower than fee for service, but they rise at about the same rate due largely to the updating of technology faced by all financing mechanisms.""3 3 32 Management of use is the source of most managed care horror stories. For example, most managed care plans have reduced their allowable inpatient days for mothers with normal vaginal deliveries. The 24 hour stay has become the norm in some parts of the country. There has been some anecdotal evidence that mothers and babies have not been adequately prepared for discharge and that appropriate home care was not available. The anecdotes were numerous enough to prompt some states to pass legislation requiring all insurance plans to cover at least two days postpartum.33 This represents an interesting turn of events. Managed care firms have been accused of micromanaging patient care; now state legislators have started to micromanage the health plans.
Although there is considerable concern about managed care today, there are signs that the best managed care companies recognise that they cannot compete on the basis of costs alone; they must show that they offer value, a measure that encompasses cost and quality. In fact, some of the largest employers in the United States are demanding that managed care plans measure and report their performance with a variety of quality indicators.32 The employers are using these report cards to select plans to offer their employees.
The The healthcare industry is often resistant to rethinking the way it does business.
Once again, there is a lot yet to learn. There is not enough evidence about how much money, if any, could be saved with no diminution or even improvement in quality. There is much work to be done in terms of continuous quality improvement and process reengineering to determine the true cost of quality; a growing number of integrated delivery systems in the United States have started to do just that. A good integrated delivery system should, by definition, be one that commits resources to this kind of work and to public education about its findings.
EXPENDITURES
We think that if policy deliberations begin by defining quality and cost, it will be easier to set expenditure goals. If quality is defined in terms of outcomes, the cost to produce the desired outcomes is measured, and the impact of improved health is understood, then policy makers and the public can decide their willingness to pay for a given level of quality. If health expenditures grow faster than the resources to finance them (be those government revenues, corporate profits, or consumer incomes), then health care will inevitably crowd out expenditures for other goods and services.34
The public may conclude that is acceptable if those expenditures are, in fact, paying for better health. Or Americans may choose to limit health care's share of the economy in the interest of economic growth, which can affect health as well.
Conclusion
The outcome of the debate on the future of the United States healthcare system will be determined, in large part, by attaining better understandings of quality, costs, control of expenditure, and their relations with each other. The keys to meeting this challenge are clarity of definitions, solid research data, and education of the public. Horror stories, political positioning, and self interest will not advance the debate. It is also critical that participants in the debate move away from their historical position that quality declines when costs (expenditures) are reduced. They should accept the challenge of redefining desired outcomes and re-engineering and inte-grating delivery systems to enhance quality. They should adopt the perspective that cost, although an important factor in decisions made by employers, patients, and policy makers, does not necessarily equate with quality.
Cost, although an important factor in decisions made by employers, patients, and policy makers, does not necessarily equate with quality.
